Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|14|5|343-351

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.14, Iss.5, 2014-10, pp. : 343-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Design and Exogenous Delivery of siRNA for Post-transcriptional Gene Silencing

By Gilmore Ian R.   Fox Stephen P.   Hollins Andrew J.   Sohail Muhammad   Akhtar Saghir  

Journal of Drug Targeting, Vol. 12, Iss. 6, 2004-07 ,pp. : 315-340

Informa Healthcare

Access to resources Recommend Favorite

SiRNA Mediated Gene Silencing: Hurdles, Strategies and Applications

By  

Pharmaceutical Nanotechnology, Vol. 3, Iss. 4, 2016-03 ,pp. : 322-333

Bentham Science Publishers

Access to resources Recommend Favorite

siRNA Delivery Using Nanocarriers - An Efficient Tool for Gene Silencing

By  

Current Gene Therapy, Vol. 10, Iss. 2, 2010-04 ,pp. : 139-155

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury

By  

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2692-2700

Bentham Science Publishers

Access to resources Recommend Favorite

Potentiality of Small Interfering RNAs (siRNA) as Recent Therapeutic Targets for Gene-Silencing

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 469-482

Bentham Science Publishers

Access to resources Recommend Favorite